1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer

Clinical trial NCT01303679 · TERMINATED

Trial details

NCT number: NCT01303679
Sponsor: ARCAGY/ GINECO GROUP
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

First Line Metastatic Breast Cancer

Start date: 2010-06-01
Primary completion: 2014-06-01
Enrollment: 117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.